GelfandJM, NeimannAL, ShinDB. Risk of myocardial infarction in patients with psoriasis. JAMA2006;296:1735–41, doi:10.1001/jama.296.14.1735.
2.
LoveTJ, QureshiAA, KarlsonEW. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol2011;147:419–24. [Epub 2010 Dec 20], doi:10.1001/archdermatol.2010.370.
3.
Villaseñor-ParkJ, WheelerD, GrandinettiL.Psoriasis: evolving treatment for a complex disease. Cleve Clin J Med2012;79:413–23, doi:10.3949/ccjm.79a.11133.
4.
[abstract]. Presented at the 2011 American Heart Association Scientific Sessions; 2011Nov12–16; Orlando, FL.
5.
[abstract]. Presented at the 2011 American Heart Association Scientific Sessions; 2011Nov12–16; Orlando, FL.
6.
NeimannAL, ShinDB, WangX. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol2006;55:829–35. [Epub 2006 Sep 25], doi:10.1016/j.jaad.2006.08.040.
7.
WangY, GaoH, LoydCM. Chronic skin-specific inflammation promotes vascular inflammation and thrombosis. J Invest Dermatol2012;132:2067–75. [Epub 2012 May 10]
8.
American Academy of Dermatology 70th Annual Meeting, San Diego, March 16-20, 2012. Available at: http://www.eurekalert.org/pub_releases/2012-03/mhi-tpt031612.php.
9.
DavidoviciBB, SattarN, PrinzJC. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol2010;130:1785–96. [Epub 2010 May 6], doi:10.1038/jid.2010.103.
